Patent ID: 7022322
Filing Date: 2006-04-04
Classification: A61K,A61P,B01D,C07K,Y10S

Abstract:
1. An immunoapheresis method of treating a patient suffering from dilated cardiomyopathy (DCM) comprising: having the patient undergo a plurality of immunoapheresis procedures comprising passing the patient's plasma over a column having coupled thereto a specific ligand selected from the group consisting of a polyclonal or monoclonal anti-human immunoglobulin antibody or a fragment thereof, protein A and protein G, followed by reinfusion of the patient's plasma into the patient, wherein at least 80 percent of the patient's immunoglobulin is removed, and wherein the immunoapheresis procedure is conducted under conditions which promote the binding of the specific ligand to immunocilobulin in the plasma.